Aggregate Payments Related To Cumulative Net Sales Thresholds.

No definition available.

Name:	icvx_AggregatePaymentsRelatedToCumulativeNetSalesThresholds
Namespace Prefix:	icvx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

License agreement expiry year

+ References

No definition available.

+ Details

Name:	icvx_LicenseAgreementExpiryYear
Namespace Prefix:	icvx_
Data Type:	dtr-types:gYearListItemType
Balance Type:	na
Period Type:	duration

- Definition

Payment of license fee.

+ References

No definition available.

+ Details

Name:	icvx_PaymentOfLicenseFee
Namespace Prefix:	icvx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Potential payment for future development and regulatory based milestone.

+ References

No definition available.

+ Details

Name:	icvx_PotentialPaymentForFutureDevelopmentAndRegulatoryBasedMilestone
Namespace Prefix:	icvx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- References

No definition available.

+ Details

Name:	icvx_PotentialPaymentsForFutureDevelopmentRegulatoryAndSalesBasedMilestones
Namespace Prefix:	icvx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- References

No definition available.

+ Details

Name:	icvx_TotalMilestonePayments
Namespace Prefix:	icvx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_CommonStockSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_TypeOfArrangementAxis=icvx_NIHAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=icvx_UWTwoThousandAndEighteenAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=icvx_UwFluLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=icvx_UTAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License Agreements - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Aug. 01, 2018
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Common stock, shares issued	39,724,867		39,429,103
NIH Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Payment of license fee	$ 100,000
Potential milestone payments	8,600
NIH Agreement \| Research and Development Expense [Member]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Payment of license fee	0	$ 0
U W Two Thousand And Eighteen Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Common stock, shares issued				192,276
Potential Payments for Future Development Regulatory and Sales Based Milestones	1,350
Total Milestone Payments	8,100
Uw Flu License Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Aggregate Payments Related To Cumulative Net Sales Thresholds	$ 6,400
License Agreement Expiry Year	2041
U T Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Potential milestone payments	$ 4,600